Mitogen-Activated Protein Kinase 3 - Analysis
Research News and Information

Monday, November 23, 2009

Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.

29 Sep 2009 OBJECTIVE: In peripheral arterial disease (PAD) patients, a limiting factor in the success of percutaneous transluminal angioplasty (PTA) is the development of restenosis secondary to vascular smooth muscle cell (SMC) proliferation. Following ... Read more...

Interactions between angiotensin II and arginine vasopressin in water homeostasis.

29 Jun 2009 Mice deficient in the angiotensin II type 1a (AT(1a)) receptor demonstrate a vasopressin-resistant nephrogenic diabetes insipidus. These knockout mice exhibit a threefold increase in 24-h urine excretion. Neither 2 weeks of exogenous vasopressin nor ... Read more...

Specific attenuation of protein kinase phosphorylation in muscle with a high mitochondrial content.

21 Jun 2009 Acute contractile activity increases the activation of protein kinases involved in signal transduction. We hypothesized that the contractile activity-induced kinase phosphorylation would occur to a lesser degree in muscle with elevated mitochondrial ... Read more...

Latest indexed articles for 'Mitogen-Activated Protein Kinase 3 - Analysis'

These are the very latest articles for this heading:

• Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty. 29 Sep 2009
• Interactions between angiotensin II and arginine vasopressin in water homeostasis. 29 Jun 2009
• Specific attenuation of protein kinase phosphorylation in muscle with a high mitochondrial content. 21 Jun 2009
• Glycogen synthase kinase 3B in bovine oocytes and granulosa cells: possible involvement in meiosis during in vitro maturation. 19 May 2009
• Measurement of phosphorylated extracellular signal-regulated kinase 1 and 2 in an undergraduate teaching laboratory with ALPHAscreen technology. 15 Mar 2009
• Analysis of protein phosphorylation by monolithic extraction columns based on poly(divinylbenzene) containing embedded titanium dioxide and zirconium dioxide nano-powders. 30 Oct 2008
• Treponema denticola peptidoglycan induces the production of inflammatory mediators and matrix metalloproteinase 9 in macrophage-like cells. 20 Oct 2008
• Effects of heparin-binding epidermal growth factor-like growth factor on cell repopulation and signal transduction in periodontal ligament cells after scratch wounding in vitro. 5 Oct 2008
• Selective inhibition of mitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death. 15 Jul 2008
• The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. 13 May 2008
• Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. 14 Apr 2008
• Contact spotting of protein microarrays coupled with spike-in of normalizer protein permits time-resolved analysis of ERBB receptor signaling. 30 Mar 2008
• Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. 8 Jan 2008
• A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein-coupled receptor 30 in some brain areas of the hamster. 30 Dec 2007
• An optimized immunohistochemical method for detection of phosphorylated mitogen-activated protein kinases. 24 Nov 2007
• Effect of an oily calcium hydroxide suspension (Osteoinductal) on human periodontal fibroblasts. An in vitro study. 25 Jun 2007
• Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. 10 Jun 2007
• Survival signaling and terminal differentiation in cholesteatoma epithelium. 30 Mar 2007
• Soluble products from Eikenella corrodens induce cell proliferation and expression of interleukin-8 and adhesion molecules in endothelial cells via mitogen-activated protein kinase pathways. 30 Jan 2007
• Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib. 29 Sep 2006

See a longer list of these articles.

Technical information about 'Mitogen-Activated Protein Kinase 3'

Definition: A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.

Registry Number: EC 2.7.1.37

Descriptor UI: D048052

Alternative terms: Mitogen-Activated Protein Kinase 3; Mitogen Activated Protein Kinase 3; Meiosis-Activated Myelin Basic Protein Kinase p44(mpk); Microtubule-Associated Protein-2 Kinase; Kinase, Microtubule-Associated Protein-2; Microtubule Associated Protein 2 Kinase; p44 MAPK; Extracellular Signal-Regulated Kinase 1; Extracellular Signal Regulated Kinase 1; PSTkinase p44mpk; p44mpk, PSTkinase; ERK1 Kinase; Kinase, ERK1; MAPK3 Mitogen-Activated Protein Kinase; MAPK3 Mitogen Activated Protein Kinase; Protein-Serine-Threonine Kinase p44(mpk);

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications;

Tree Number: D08.811.913.696.620.682.700.567.342.750; D08.811.913.696.620.682.700.646.750.249.750; D12.644.360.450.169.750; D12.776.476.450.169.750;

History Note: 2005(2000)